CAS 58668-21-6

4-Pyrimidinecarboxylic acid, 5-bromohexahydro-2,6-dioxo-

Description:

4-Pyrimidinecarboxylic acid, 5-bromohexahydro-2,6-dioxo- is a chemical compound characterized by its pyrimidine ring structure, which is a six-membered aromatic ring containing two nitrogen atoms at positions 1 and 3. The presence of a carboxylic acid functional group (-COOH) indicates its acidic properties, while the bromine substituent at the 5-position introduces halogen characteristics, potentially influencing its reactivity and solubility. The hexahydro-2,6-dioxo moiety suggests the presence of a saturated cyclic structure with two carbonyl (C=O) groups, contributing to the compound's overall stability and reactivity. This compound may exhibit biological activity, making it of interest in pharmaceutical research. Its molecular structure allows for various interactions, including hydrogen bonding and coordination with metal ions, which can be relevant in coordination chemistry and drug design. As with many organic compounds, its physical properties, such as melting point, boiling point, and solubility, would depend on the specific molecular interactions and the environment in which it is studied.

Formula: C₅H₅BrN₂O₄

5-Bromohexahydro-2,6-dioxo-4-pyrimidinecarboxylic Acid-15N2

Controlled Product

CAS: 58668-21-6

Applications 5-Bromohexahydro-2,6-dioxo-4-pyrimidinecarboxylic Acid-15N2 is an intermediate used in the synthesis of Orotic Acid-15N2 Monohydrate (O691504), which is a labeled analogue of Orotic Acid Monohydrate (O691500) that is used in the preparation of therapeutic agents for chronic obstructive pulmonary disease (COPD) treatment. Also, it is the labeled form of 5-Bromohexahydro-2,6-dioxo-4-pyrimidinecarboxylic Acid (B699363), an intermediate in synthesizing Orotic Acid Monohydrate (O691500), which is used in the preparation of therapeutic agents for chronic obstructive pulmonary disease (COPD) treatment.

Formula: C₅H₅Br₁₅N₂O₄

Color and Shape: Neat

Molecular weight: 238.995

Ref: TR-B699364